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ABSTRACT
Objective: The present study was undertaken to characterize CTX-M ESBL-producing Klebsiella 
pneumoniae collected from hospitals in different cities of Brazil. Material and Methods: Eighty-five 
K. pneumoniae strains isolated from hospitalized patients in six different hospitals of three cities 
of Brazil were analyzed. ESBL production was confirmed by the standard double-disk synergy test 
and the Etest®. The MIC50 and MIC90 for ESBL-producing isolates were determined by the Etest® 
method. The antimicrobial susceptibilities of bacterial isolates were determined using the agar dif-
fusion method according to the CLSI. Screening for blaTEM, blaSHV, blaCTX-M genes and class 1 integron 
was performed by PCR amplification. To determine the genomic diversity of CTX-M-producers, 
isolates were analyzed by macrorestriction profile analysis following PFGE. Results and Discus-
sion: Seventy-one K. pneumoniae isolates were ESBL-producing. PCR and sequencing experiments 
detected 38 CTX-M-producing K. pneumoniae belonged to groups CTX-M 1, CTX-M 2, CTX-M 8 
and CTX-M 9. The association of different types ESBL (CTX-M, SHV and TEM) was frequent. All 
K. pneumoniae isolates carried class 1 integron. PFGE analysis revealed thirty-one clonal types 
among CTX-M-producing isolates. The data presented herein illustrate the diversity of genotypes of 
CTX-M producing K. pneumoniae among Brazilians hospitals.
Keywords: Klebsiella pneumoniae; β-lactamases; genotype.
moniae isolates have been reported from 
South America, Asia and Europe.5-8 In some 
of those settings, rates of CTX-M-produc-
tion as high as 58.5% in K. pneumoniae have 
been reported,7 and South America appears 
as an important source of CTX-M type 
ESBL.9,10
In the present study we describe the mo-
lecular characterization of CTX-M-produc-
ing K. pneumoniae clinical strains isolated 
from six different hospitals in three cities of 
Brazil.
MATERIAL AND METHODS
Bacterial isolates
We analyzed 85 non-replicate K. pneumoniae 
strains isolated from hospitalized patients in 
six different hospitals of three cities of Brazil 
(Niterói, Rio de Janeiro, and São Paulo), from 
May 2003 to September 2006. The isolates were 
recovered from urine (n = 25), blood (n = 25), 
INTRODUCTION 
Klebsiella pneumoniae is an opportunistic 
pathogen that has emerged as an impor-
tant cause of hospital-acquired infections, 
especially in hospitalized immunocompro-
mised patients with severe underlying dis-
eases or admitted to neonatal intensive-care 
units.1 The worldwide spread of plasmid-
encoded extended-spectrum β-lactamases 
(ESBLs)-producing Klebsiella strains which 
are resistant to the bactericidal activity 
of all cephalosporins is also considered a 
great threat.2 Various types of ESBL have 
been described worldwide.3 In particular, 
CTX-M-type ESBLs have become the pre-
vailing non-TEM, non-SHV ESBL among 
Enterobacteriaceae and is recognized as a 
rapidly growing family of ESBLs that pref-
erentially hydrolyze cefotaxime rather than 
ceftazidime.2,4,5
In recent studies, high rates of CTX-M 
enzymes among ESBL-producing K. pneu-
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pulmonary secretion (n = 5), catheter (n = 5), and other sites 
(n = 25). Preliminary identification of the isolates was 
accomplished using the Vitek® (bioMérieux) automated 
system and established biochemical procedures.
Antimicrobial susceptibility testing
ESBL production was confirmed by the standard double-
disk synergy test and the Etest® (ceftazidime/ceftazidime + 
clavulanic acid) (AB Biodisk, Solna, Sweden). The MIC50 
(minimum concentration capable to inhibit 50% of the iso-
lates) and MIC90 (minimum concentration capable to inhibit 
90% of the isolates) values of five antimicrobial agents (az-
treonam, cefepime, ceftazidime, cefotaxime, and imipinem) 
for ESBL-producing isolates were determined by the Etest® 
method. All K. pneumoniae isolates were also tested against 
the following antimicrobial agents: gentamicin (CN); ami- 
kacin (AK); norfloxacin (NOR); ciprofloxacin (CIP); 
aztreonam (ATM); cefepime (FEP); imipinem (IPM); and 
trimethoprim-sulphametoxazole (SXT) by the disk diffusion 
method, and the results were interpreted based on the CLSI 
guidelines.11 Quality control was carried out using stand-
ard strains of Escherichia coli (ATCC 25922), Pseudomonas 
aeruginosa (ATCC 27953), Staphylococcus aureus (ATCC 
27953), and Klebsiella pneumoniae (ATCC 700803).
Characterization of β-lactamase-encoding genes
Screening for resistance genes was performed by PCR 
amplification using previously reported conditions and 
primer sets for detection of blaTEM, blaSHV,12 blaCTX-M13 
and class 1 integron.14 PCR products were sequenced 
with the ABI PRISM Dye Terminator Cycle Sequecing 
Ready Reaction Kit on a 3730 DNA Sequence Analyzer 
(Applied Biosystem). Obtained sequences were aligned 
and compared with those in GenBank (http://www.ncbi.
nlm.nih.gov/BLAST).
Pulsed-field gel electrophoresis (PFGE) typing
Clonal relationships were studied by pulsed field gel elec-
trophoresis (PFGE) of SpeI-digested genomic DNA with 
a CHEF DRII apparatus (Bio-Rad Laboratories, Hemel 
Hempstead, United Kingdom).15 Band patterns were com-
pared visually and interpreted according to the criteria 
established by Tenover et al.,16 and analyzed with BioNu-
merics v.4.0 software (Applied Maths, Sint-Martins-Latem, 
Belgium). Isolate clustering were performed by the un-
weighted pair group method using arithmetic averages 
(UPGMA) in combination with Dice similarity coefficient.
RESULTS
Of 85 K. pneumoniae isolates, 71 (84%) were 
ESBL-producing bacteria as determined by the double-
disk synergy test and the Etest®. In 71 ESBL-producing 
isolates, the MIC50/MIC90 values (µg/mL) of aztreonam, 
cefepime, ceftazidime, cefotaxime and imipinem were 
16/256, 6/16, 32/256, 32/256 and 0.125/0.19, respective-
ly. In this study, a multiresistant pattern was observed 
in ESBL-producing K. pneumoniae isolates and we de-
tected the co-resistance of gentamicin (70%), amikacin 
(36%), norfloxacin (46%), ciprofloxacin (49%), aztreon-
am (68%), cefepime (41%), and trimethoprim-sulpha-
metoxazole (71%).
Sixty-five (92%) of the isolates were positive 
for blaTEM and 32 (45%) were positive for blaSHV. All 
ESBL-producing isolates had class 1 integron. The ge-
netic analysis of these isolates by PCR revealed that 38 
of 71 (54%), from four different hospitals (Niterói and 
Rio de Janeiro cities), were positive for the CTX-M gene. 
The remaining 33 isolates (46%) were negative for this 
gene and these CTX-M gene-negative isolates showed 
other ESBL type (SHV and TEM) (Table 1). The associa-
tion of different types of ESBL was frequent. 
Considering the CTX-M-producers, 53% of these 
co-produced TEM and SHV, and 47% co-produced only 
TEM. It was possible to identify 4 CTX-M clusters. The 
genotyping of 38 CTX-M gene-positive isolates showed 
that 1 (3%), 23 (61%), 7 (18%) and 4 (11%) isolates be-
longed to groups CTX-M 1, CTX-M 2, CTX-M 8 and 
CTX-M 9, respectively. The remaining three isolates 
were not classified into these groups.
The PFGE analysis of CTX-M-producing 
K. pneumoniae isolates showed 31 clonal types, A – EE, 
considering the genetic relatedness strain (defined as 
Dice coefficients of < 85%) (Figure 1). Based on these 
data, a diversity of clones within the hospitals was 
found. However, two hospitals (HU1 ad HU5) present-
ed the same clonal group of CTX-M-2, characterized 
as genotype O. All CTX-M-producers genotypes were 
characterized as multidrug-resistant (Table 2).
Table 1. Frequency of β-lactamases genes detected in 
isolates (n = 71)
β-lactamases genes Number of isolates (%)
blaCTX-M 3 (4)
blaCTX-M; blaTEM 18 (26)
blaCTX-M; blaTEM; blaSHV	 20	(29)
blaCTX-M; blaSHV	 0	(0)
blaTEM 18 (26)
blaTEM; blaSHV 9 (13)
blaSHV 3 (4)
Total	 71	(100)
Chagas, Alves, Vallim et al.
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In clinical strains, CTX-M-coding genes have been 
commonly located on plasmids and these plasmids can 
also carry genes for resistance to multiple other antibi-
otics, including aminoglycosides, chloramphenicol, sul-
fonamide, trimethoprim, and tetracycline. Resistance 
of ESBL-producing isolates to other classes of antimi-
crobial agents shown in this report has been confirmed 
by other studies.5,20 Among Enterobacteriaceae, these 
resistance pattern was commonly associated with a few 
types of integrons.
In this study, all isolates that carried the gene blaCTX-M 
also contained class 1 integrons. Insertion sequences 
(IS) might be involved in the mobilization of blaCTX-M 
genes.21 The blaCTX-M genes have also been associated 
with ISCR1, which is often found downstream of com-
plex class 1 integrons.22 
CTX-M-2, CTX-M-8 and CTX-M-9 groups were the 
most frequently detected CTX-M-type enzymes among 
ESBL-producing Enterobacteriaceae isolates from South 
American countries.4,9,23 In the present study, CTX-M 2 
(61%) was the predominant cluster. CTX-M-2 was first 
characterized and appears to be dominant in Argenti-
na.20 Studies carried out in Europe have shown that the 
occurrence of the blaCTX-M-2 group is rare. Recent studies 
in Southeast Brazil have demonstrated the presence of 
blaCTX-M-2 gene in K. Pneumoniae.24,25 Dissemination 
of CTX-M-9 and CTX-M-8 clusters has also been re-
ported in Brazil.4,26,27
Many of the CTX-M positive isolates harbored oth-
er β-lactam resistance enzymes and the association of 
types TEM, SHV and CTX-M (n = 20) was more fre-
quent. Previous studies have shown that ESBL medi-
ating plasmids may carry more than one β-lactamase 
gene and that they may be responsible for high-level 
β-lactamase resistance phenotypes.28 In our study, 
the resulting PFGE gel of CTX-M-producing 
K. pneumoniae isolates showed genotypic diversity. 
However, two hospitals presented the same clonal 
group, characterized as genotype O, CTX-M-2 produc-
ers, suggesting intrahospital dissemination.
The high levels of CTX-M ESBL detected are wor-
risome and warrant special attention by both the clini-
cian and the microbiology laboratory. While the former 
has to re-evaluate the antibiotic policies, the laboratory 
must be capable to readily identify these isolates. Given 
the degree to which these CTX-M-producing microor-
ganisms have spread, they should be seen as a city public 
health issue instead of a problem of each hospital. Wide-
spread use of antimicrobial therapy has often been held 
responsible for the occurrence of multiresistant Klebsiel-
la strains in hospitals.29 Our data corroborate the impor-
tance of antibiotic use restriction and implementation of 
preventive measures.
Figure 1: PFGE of SpeI-digested DNA of 38 CTX-M-producing 
Klebsiella pneumoniae isolates.
DISCUSSION 
The prevalence of K. pneumoniae producing ESBL 
varies between different countries and regions. The 
clinical relevance of multidrug resistance among 
ESBL-producing Klebsiella spp. is of great concern due 
to the limited therapeutic options and increased risk of 
treatment failure in patients infected with such strains.17 
In Brazil, there has been some reports of multi-drug 
resistant hospital-acquired K. Pneumoniae.18,19 In our 
study, 71 (84%) were ESBL positive by the double-disk 
synergy test and the Etest® and this value is considered 
high. This highlights the importance of investigating re-
sistance mechanisms in hospitals.
Among the antimicrobials evaluated for minimum 
inhibitory concentration, the carbapenemics presented 
the best potency (MIC50), with imipenem (0.125 μg/mL). 
Carbapenems such as imipenem and meropenem are 
recommended as therapy of choice for severe infec-
tions caused by CTX-M- and other types ESBL-pro-
ducing bacteria. Most CTX-M positive isolates exhib-
ited resistance to non-β-lactam antibiotics displaying 
co-resistance for gentamicin, amikacin, norfloxacin, 
ciprofloxacin, aztreonam, cefepime, and trimetho-
prim-sulphametoxazole.
2211 H1 A
1677-01	 H1	 A1
563 H1 B
1368 H1 C
21580	 H2	 D
91 H4 E
33-10	 H1	 F
166 H1 G
2256-01	 H1	 H
758 H1 I
2221 H1 J
1636-01	 H1	 J1
621 H1 K
204	 H1	 K1
22856 H3 L
2332 H1 M
22200	 H2	 N
25646 H2 N1
968 H1 O
50266	 H5	 O1
76102	 H1	 P
74401	 H1	 P1
2194 H1 Q
662 H1 R
1051	 H1	 S
2305	 H1	 S1
820839	 H2	 T
30800	 H2	 U
50088	 H5	 V
127 H4 W
66418 H2 X
24218 H2 Y
539 H4 Z
523 H4 AA
33155 H2 BB
26306	 H2	 CC
27341 H2 DD
930616	 H2	 EE
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Table 2. Characteristics of CTX-M-producing K. pneumoniae isolated (n = 38) 
Hospital Isolate nº  Specimen Resistance and ß-lactamase detected Phylo- 
(city)   co-resistance of ESBL-  genetic 
   producing isolates   group
 1368 Bronchial secretion CN, KF, CIP, NOR, FEP,  TEM, SHV,  C 
   SXT, ATM, CTX, CAZ CTX-M-2 group 
	 1051	 Bronchial	secretion	 CN,	CTX	 TEM,	CTX-M-2	group	 S 
 968 Sputum CN, NOR, CIP, CTX, FEP TEM, CTX-M-2 group O 
 563 Bronchial secretion CN, NOR, CIP, CTX,  TEM, CTX-M-2 group B 
   FEP, ATM, SXT 
 652 Skin  AK, CN, CTX, ATM TEM, SHV,  R 
    CTX-M-9 group 
 758 Pulmonary secretion AK, CN, CAZ, CTX,  TEM, SHV,  I 
   ATM, SXT CTX-M-2 group 
	 744-01	 Pulmonary	secretion	 AK,	NOR,	CIP,	CTX,	SXT	 TEM,	CTX-M-2	group	 P1 
	 761-02	 Nasal	swab	 AK,	NOR,	CIP,	CAZ,		 TEM,	CTX-M-2	group	 P 
   CTX, ATM, SXT
H U1 2332 Urine  CN, CTX, ATM TEM, CTX-M-2 group M 
(Niterói)	 1636-01	 Pulmonary	secretion	 CN,	CAZ,	CTX,	FEP,	ATM	 TEM,	SHV,		 J1 
    CTX-M-2 group 
 2211 Pulmonary secretion CN, NOR, CIP, CAZ, TEM, SHV,  A 
   CTX, ATM, SXT CTX-M-2 group 
	 1677-01	 Catheter		 CN,	NOR,	CIP,	CAZ,		 TEM,	SHV,		 A1 
   CTX, FEP, ATM SXT CTX-M-2 group 
	 33-10	 Blood	 AK,	CN,	CAZ,		 TEM,	SHV,		 F 
   CTX, ATM, SXT CTX-M-2 group 
	 2256-01	 Pulmonary	secretion	 CN,	CTX,	AK,	NOR,	CIP,		 TEM,	SHV,	 H 
   CAZ, FEP, ATM, SXT CTX-M-2 group 
	 2305	 Tracheal	secretion	 CN,	CTX	 TEM,	SHV,		 S1 
    CTX-M-2 group 
	 204	 Urine		 AK,	CN,	CAZ,	CTX,		 TEM,	CTX-M-2	group	 K1 
   FEP, ATM 
 621 Urine  AK, CN, CAZ, CTX,  TEM, CTX-M-2 group K 
   FEP, ATM, SXT 
 2194 Urine  CN, NOR, CIP, CAZ,  TEM, SHV,  Q 
   ATM, SXT CTX-M-9 group 
 166 Blood  CN, CAZ, CTX, ATM, SXT TEM, CTX-M-ND G 
 2221 Blood  AK, CN, CAZ,  TEM, SHV,  J 
   CTX, FEP, ATM CTX-M-2 group 
cont.
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Table 2. Characteristics of CTX-M-producing K. pneumoniae isolated (n = 38) (Cont.)
Hospital Isolate nº  Specimen Resistance and ß-lactamase detected Phylo- 
(city)   co-resistance of ESBL-  genetic 
   producing isolates   group
 24218 Blood NOR, CIP, CTX, FEP TEM, SHV, CTX-M-8 group Y 
	 30800	 Bronchial	secretion	 CN,	CTX,	FEP,	ATM	 TEM,	CTX-M-8	group	 U 
 25646 Urine AK, CN, NOR,  TEM, SHV,  N1 
   CIP, CTX, SXT CTX-M-8 group 
 65416 Urine CN, NOR, CIP, CAZ,  TEM, SHV,  X 
   CTX, FEP, ATM, SXT CTX-M-1 group 
H U2	 21530	 Urine	 CN,	CIP,	CTX,	FEP,	ATM	 TEM,	CTX-M-2	group	 D 
(Rio	de	Janeiro)	 26306	 Blood	 AK,	CN,	NOR,	CIP,	 TEM,	CTX-M-8	group	 CC 
   CTX, FEP, SXT 
	 820839	 Urine	 CN,	NOR,	CIP,	CYX,		 TEM,	SHV,		 T 
   FEP, ATM, SXT CTX-M-2 group 
	 930616	 Bronchial	secretion	 CN,	CTX,	FEP,	ATM	 TEM,	CTX-M-2	group	 EE 
 27341 Blood AK, CN, NOR, CIP,  TEM, SHV,  DD 
   CTX, FEP, SXT CTX-M-8 group 
 33155 Bronchial secretion AK, CN, NOR, CIP,  TEM, CTX-M-ND BB 
   CTX, FEP, SXT 
	 22200	 Urine		 AK,	CN,	NOR,		 TEM,	SHV,	CTX-M-2	group	 N 
   CIP, CTX, SXT
H U3 22856 Urine  AK, CN, NOR CIP,  TEM, SHV,  L 
(Rio de Janeiro)   ATZ, CAZ, CTX, SXT CTX-M-9 group
H U4 91 Blood NOR, CIP, CTX, FEP, SXT TEM, CTX-M-8 group E 
(Rio de Janeiro) 127 Blood CAZ, CTX, ATM, SXT TEM, SHV, CTX-M-ND W 
 523 Blood AK, CN, SXT TEM, CTX-M-9 group AA 
 539 Blood AK, CN, NOR, CAZ, SXT TEM, CTX-M-9 group Z
H U5	 50088	 Blood	 CN,	CIP,	FEP,	ATM,	SXT	 TEM,	SHV,	CTX-M-2	group	 V 
(Rio	de	Janeiro)	 50266	 Urine		 AK,	CN,	ATM	 TEM,	SHV,	CTX-M-2	group	 O1
AK, amikacin; ATM, aztreonam; CAZ, ceftazidime; CIP, ciprofloxacin; CN, gentamicin; CTX, ceftriaxone; FEP, cefepime; IPM, 
imipinem; NOR, norfloxacin; SXT, trimethoprim-sulphametoxazole; ND, not determined.
CONCLUSION
In conclusion, CTX-M enzymes have emerged in our hos-
pitals. The intensive use of broad-spectrum cephalospor-
ins such as cefotaxime could account for the emergence 
of the CTX-M plasmid-mediated enzymes among patho-
gens. Several groups of bla genes were detected in clinical 
samples in the studied hospitals, but the blaCTX-M 2 was the 
predominant. The data presented herein illustrate the di-
versity of genotypes of CTX-M producing K. pneumoniae 
among hospitals and the intrahospital dissemination of these 
genotypes was uncommon. Thus, the high prevalence of 
CTX-M K. pneumoniae in our hospitals is probably not a 
consequence of the transmission of a common strain be-
tween patients. Diversity of genotypes was also described 
in other studies suggested that the increase of ESBL 
K. pneumoniae was mainly due to horizontal dissemina-
tion of gene transfer between isolates.30 In contrast, it is im-
portant to note that currently there is a worldwide spread 
of ESBL and KPC-producing K. pneumoniae, which seems 
to occur due to the dissemination of specific clones ST258, 
ST11 and ST437 in Brazil.31,32
CTX-M-producing K. pneumoniae in Brazil
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